Researchers found that certain genes linked to mitochondrial function may play a significant role in intervertebral disc degeneration (IVDD), a condition that can lead to back pain and reduced mobility. This study highlights the importance of mitochondrial health in maintaining spinal integrity and suggests that targeting specific genes could lead to new treatment options for those suffering from IVDD.

For people concerned about aging and maintaining a healthy spine, this research indicates that genetic factors related to mitochondrial function might influence your risk of developing IVDD. The study identified five key genes, particularly one called glycine amidinotransferase (GATM), which showed a strong association with a lower risk of IVDD. This means that having higher levels of GATM could potentially protect against this common condition, which affects many adults as they age.

The research utilized advanced techniques to analyze genetic data from large studies, making the findings more reliable. While the results are promising, they are based on genetic analysis and not yet on clinical trials involving treatments. This means that while the connections are strong, more research is needed to confirm how these findings can be translated into effective therapies for IVDD.

If you’re interested in supporting your spinal health, consider discussing with your healthcare provider ways to promote mitochondrial function through lifestyle changes, such as regular exercise and a balanced diet rich in antioxidants. While the specific drugs targeting GATM identified in this study are not yet available for general use, staying informed about advancements in this area could be beneficial for future treatment options.

Source: academic.oup.com